Fig. 7.
(A) Western blot analysis of PSer133-CREB and total CREB protein performed in HEL cells before (lane 1) and after stimulation with 100 ng/mL of TPO (lanes 2 through 5) or FK (lanes 6 and 7) in the absence (positive control, lane 2) or presence of 10−5 mol/L (lanes 3 and 7) or 5 × 10−5mol/L (lanes 4 and 5) of the specific MAPK inhibitor, PD 98059. Results from one representative experiment of three separate experiments are shown. The densitometric analysis is expressed in arbitrary units (a.u.). (B) Flow cytometric analysis of integrin αIIbβ3 receptors at the plasma membrane of HEL cells left untreated or treated for 48 hours with 100 ng/mL TPO in the absence or presence of 5 × 10−5 mol/L PD98059, which was readded in culture every 8 hours. Results from one representative experiment of three separate experiments are shown. X axis: relative αIIbβ3 (CD41a) fluorescence intensity. Y axis: relative cell number. (C) Assay of MAPK catalytic activity performed in HEL cells treated with TPO (100 ng/mL) or Epo (2 U/mL) for various time points. Data are expressed in cpm as the means ± SD of four separate experiments performed in duplicate.